Test Details: Endometrial cancer is the most common cancer affecting the female reproductive organs and approximately 2%-5% of endometrial cancer cases are hereditary and related to Lynch syndrome. Endometrial Cancer Panel is a Next Generation Sequencing (NGS) based assay that analyzes relevant genes, having a well-established association with high or moderate risk for endometrial cancer, from DNA (POLE, TP53, MLH1, MSH2, MSH6, PMS2).